Physician profile
George Card
NPI 1750364253
$1,421.98
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $97.71 · 2021: $292.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $391.20 | 2019-2021 | |
| Optinose US, INC. | $308.98 | 2019-2021 | |
| Aerin Medical INC. | $151.55 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $150.55 | 2019 | |
| Acclarent, INC | $144.56 | 2019-2021 | |
| Arrinex, INC. | $131.44 | 2019 | |
| Genzyme Corporation | $64.21 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $28.46 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.73 | 2019 | |
| Grifols USA, LLC | $13.19 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.11 | 2019 | |
| Glenmark Therapeutics INC. | $12.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Card listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.